In the study by Napoli et al. (2002), a three-month study of HF patients (NYHA Class II-III), VO2max increased significantly from 20 ± 2 to 26 ± 2 mL/kg/min (p = 0.05) following GH therapy. The gene discussed is GH1; the disease is hydrops fetalis.